Genzyme Corporate Research Search Genzyme Websites
Gaucher Disease Treatment Information for Parents and FamiliesGaucher Disease Treatment Information for Health Care Providers
Return to Home Page


Search

Health Care Professionals
Disease Information
Genetics & Gaucher
Signs & Symptoms
Disease Progression
Diagnosing Gaucher Disease
Diagnostic Case Study
Testing
About Cerezyme
Safety
Disease Management
Ordering & Billing
Resources & Support
Prescribing Information (PDF)

Diagnosing Gaucher Disease
The challenges of diagnosing Gaucher disease

Gaucher disease can pose a challenge to diagnose, despite the availability today of accurate, non-invasive diagnostic tests (enzyme assays and DNA analysis). Misdiagnosis is not unusual and it can delay treatment and thus compromise successful treatment outcomes.

The difficulty arises in part because of the relative rarity of the disease--some practitioners may not even consider testing specifically for it, especially since clinical signs and symptoms may suggest other diseases.[1,2] Moreover, the disease’s clinical course can be unpredictable; signs and symptoms may take years to emerge and may progress at varying rates,[1,2] further complicating the question of which tests to order.

Common misdiagnoses

Many of Gaucher disease’s presenting symptoms--from distended abdomen to bone pain to hematological complications--are found with other more common diseases. Thus it’s not unusual for physicians to suspect other disorders and initially misdiagnose Gaucher patients. Some of the most common misdiagnoses include: [4]

Leukemia
Lymphoma
Bleeding disorders
Osteomyelitis
Legg-Calvé-Perthes

In addition, other diseases sometimes present with engorged cells that resemble Gaucher cells, which can be easily misdiagnosed.[3] Conditions for which these “pseudo-Gaucher cells” have been detected include:

Chronic granulocytic leukemia
Multiple myeloma
Hodgkin’s disease
Thalassemia



References

1. Beutler E, Grabowski G. Gaucher disease. In:Scriber CR, Beaudet AL, Sly WS, et al, eds. The Metabolic and Molecular Bases of Inherited Disease. 7th ed. New York, NY: McGraw-Hill; 1995;2:2641-2661.

2. Cox TM, Schofield JP. Gaucher's disease: clinical features and natural history. Bailliere's Clinical Haematology. 1997;10(4):657-689.

3. Pastores GM. Pathological features of Gaucher’s Disease. Bailliere’s Clinical Hematology. 1977; 10(4): 739-749.

4. Grabowski GA. Lysosomal storage diseases. In: Braunwald E, Fauci AS, eds. Harrison's Principles of Internal Medicine. 15th ed. New York, NY: McGraw-Hill; 2001:2276-2281.


Highlights
Did You Know...
Cerezyme (imiglucerase for injection) is the first preparation of glucocerebrosidase, the enzyme deficient in Gaucher disease, produced using recombinant DNA technology.

Resources
Interested in regular email updates with the latest on Gaucher disease and its treatment?
Sign up for our Cerezyme Medical Network
.

Contact Information
Genzyme Therapeutics
500 Kendall Street
Cambridge, MA 02142

800-745-4447
617-768-9000

Contact Genzyme